News
ADVANCED THERAPIES | Vertex, CRISPR To Submit Exa ...thalassaemia.org.cy
thalassaemia.org.cy
“We are pleased to have concluded our exa-cel pre-submission meetings with regulators and are excited that FDA has granted a rolling review,” said Nia Tatsis Ph ... “We are pleased to have concluded our exa-cel pre-submission meetings with regulators and are excited that FDA has granted a rolling review,” said Nia Tatsis Ph ...
Business Wiremoneyspecial.de
www.moneyspecial.de
... Nia Tatsis, Ph.D., Executive Vice President, Chief Regulatory and Quality Officer at Vertex. "The FDA's granting of a priority review further reinforces the Nia Tatsis, Ph.D., Executive Vice President, Chief Regulatory and Quality Officer at Vertex. "The FDA's granting of a priority review further reinforces the ...
News - Full StoryTickerTech.com
www.tickertech.com
... Nia Tatsis, Ph.D., Executive Vice President, Chief Regulatory and Quality Officer at Vertex. "The FDA's granting of a priority review further reinforces the Nia Tatsis, Ph.D., Executive Vice President, Chief Regulatory and Quality Officer at Vertex. "The FDA's granting of a priority review further reinforces the ...
2021's Fiercest Women in Life SciencesBioscienceLA
www.biosciencela.org
— Or Nia Tatsis, who rarely saw other women in academia during her training but now ensures the next generation will because of diversity — Or Nia Tatsis, who rarely saw other women in academia during her training but now ensures the next generation will because of diversity ...
sortiert nach Relevanz / Datum